Erratum: Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone (Virology (2004) 321 (235-246) DOI: 10.1016/j.virol.2003.12.015;Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone

Virology

Volumn 321, Issue 2, 2004, Pages 235-246

  Balasuriya, Udeni B R ^a   Dobbe, Jessika C ^b   Heidner, Hans W ^c   Smalley, Victoria L ^a   Navarrette, Andrea ^a   Snijder, Eric J ^b   MacLachlan, N James ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

cDNA clone; Chimeric viruses; Envelope; Equine arteritis virus; Neutralization

Indexed keywords

COMPLEMENTARY DNA; ENVELOPE PROTEIN; M PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTISERUM; VIRUS DNA;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; EQUINE VIRAL ARTERITIS VIRUS; LABORATORY; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; SUBSTITUTION REACTION; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS STRAIN;

EQUIDAE; EQUINE ARTERITIS VIRUS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; SUIDAE;

EID: 1642446607     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.06.031     Document Type: Erratum

References (44)

1. Balasuriya U.B.R., Rossitto P.V., DeMaula C.D., MacLachlan N.J. A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies. J. Gen. Virol. 74:1993;2525-2529.
2. L) of equine arteritis virus. Virology. 207:1995;518-527.
3. L envelope glycoprotein. Virology. 214:1995;690-697.
4. L envelope glycoprotein. Virology. 232:1997;114-128.
5. Balasuriya U.B.R., Evermann J.F., Hedges J.F., McKeirnan A.J., Mitten J.Q., Beyer J.C., McCollum W.H., Timoney P.J., MacLachlan N.J. Serologic and molecular characterization of an abortigenic strain of equine arteritis virus derived from infective frozen semen and an aborted equine fetus. J. Am. Vet. Med. Assoc. 213:1998;1586-1589.
6. Balasuriya U.B.R., Hedges J.F., Timoney P.J., McCollum W.H., MacLachlan N.J. Genetic stability of equine arteritis virus during horizontal and vertical transmission in an outbreak of equine viral arteritis. J. Gen. Virol. 80:1999;1949-1958.
7. Balasuriya U.B.R., Snijder E.J., van Dinten L.C., Heidner H.W., Wilson W.D., Hedges J.F., Hullinger P.J., MacLachlan N.J. Equine arteritis virus derived from an infectious cDNA clone is attenuated and genetically stable in infected stallions. Virology. 260:1999;201-208.
8. Balasuriya U.B.R., Heidner H.W., Hedges J.F., Williams J.C., Davis N.L., Johnston R.E., MacLachlan N.J. Expression of two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. J. Virol. 74:2000;10623-10630.
9. Balasuriya U.B.R., Heidner H.W., Davis N.L., Wagner H.M., Hullinger P.J., Hedges J.F., Williams J.C., Johnston J.E., Wilson W.D., Liu I.K. Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses. Vaccine. 20:2002;1609-1627.
10. Balasuriya U.B.R., Hedges J.F., Smalley V.L., Navarrette A., McCollum W.H., Timoney P.J., Snijder E.J., MacLachlan N.J. Genetic characterization of equine arteritis virus during persistent infection of stallions. J. Gen. Virol. 85:2004;379-390.
11. Castillo-Olivares J., Wieringa R., Bakoyi T., de Vries A.A.F., Davis-Poynter N.J., Rottier P.J. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain. J. Virol. 77:2003;8470-8480.
12. Cavanagh D. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch. Virol. 142:1997;629-633.
13. L. J. Gen. Virol. 76:1995;1989-1998.
14. L protein as a target for virus neutralization. J. Gen. Virol. 75:1994;2439-2444.
15. de Vries A.A.F., Chirnside E.D., Horzinek M.C., Rottier P.J.M. Structural proteins of equine arteritis virus. J. Virol. 66:1992;6294-6303.
16. de Vries A.A.F., Post S.M., Raamsman M.J.B., Horzinek M.C., Rottier P.J.M. The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. J. Virol. 69:1995;4668-4674.
17. de Vries A.A.F., Horzinek M.C., Rottier P.J.M., de Groot R.J. The genome organization of the Nidovirales: similarities and differences between arteri-, toro-, and coronaviruses. Semin. Virol. 8:1997;33-47.
18. de Vries A.A.F., Glaser A.L., Raamsman M.J., de Haan C.A., Sarnataro S., Godeke G.J., Rottier P.J. Genetic manipulation of equine arteritis virus using full-length cDNA clones: separation of overlapping genes and expression of a foreign epitope. Virology. 270:2000;84-97.
19. Dobbe J.C., van der Meer Y., Spaan W.J.M., Snijder E.J. Construction of chimeric arteriviruses reveals that the ectodomain of the major glycoprotein is not the main determinant of equine arteritis virus tropism in cell culture. Virology. 288:2001;283-294.
20. Doll E.R., Bryans J.T., McCollum W.H., Crowe M.E.W. Isolation of a filterable agent causing arteritis of horses and abortion by mares. Its differentiation from the equine abortion (influenza) virus. Cornell Vet. 47:1957;3-41.
21. Doll E.R., Bryans J.T., Wilson J.C., McCollum W.H. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet. 48:1968;497-524.
22. Edwards S., Castillo-Olivares J., Cullinane A., Lable J., Lenihan P., Mumford J.A., Paton D.J., Pearson J.E., Sinclair R., Westcott D.G.F., Wood J.L.N., Zientara S., Nelly M. International harmonization of laboratory diagnostic tests for equine viral arteritis. Wernery U., Wade J.F., Mumford J.A., Kaaden O.-R. Equine Infectious Diseases VIII, Proceedings of the Eight International Conference, Dubai 1988. 1999;359-362 R&W Publications (Newmarket) Ltd. Suffolk, UK.
23. L associated with neutralization resistance. J. Gen. Virol. 76:1995;2223-2233.
24. Hedges J.F., Balasuriya U.B.R., Timoney P.J., McCollum W.H., MacLachlan N.J. Genetic variation in open reading frame 2 of field isolates and laboratory strains of equine arteritis virus. Virus Res. 42:1996;41-52.
25. Hedges J.F., Balasuriya U.B.R., Timoney P.J., McCollum W.H., MacLachlan N.J. Genetic divergence with emergence of phenotypic variants of equine arteritis virus during persistent infection of stallions. J. Virol. 73:1999;3672-3681.
26. Landt O., Grunert H.-P., Hahn U. A general method for rapid site-directed mutagenesis using the polymerase chain reaction. Gene. 96:1990;125-128.
27. MacLachlan N.J., Balasuriya U.B.R., Hedges J.F., Schweidler T.M., McCollum W.H., Timoney P.J., Hullinger P.J., Patton J.F. Serologic response of horses to the structural proteins of equine arteritis virus. J. Vet. Diagn. Invest. 10:1998;229-236.
28. McCollum W.H. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus. Am. J. Vet. Res. 47:1986;1931-1934.
29. McCollum W.H., Timoney P.J. Experimental observation on the virulence of isolates of equine arteritis virus. Wernery U., Wade J.F., Mumford J.A., Kaaden O.-R. Equine Infectious Diseases VIII. 1999;558-559 R&W Publications (Newmarket) Limited, Newmarket, UK.
30. McCollum W.H., Timoney P.J., Lee J.W. Jr., Habacker P.L., Balasuriya U.B.R., MacLachlan N.J. Features of an outbreak of equine viral arteritis on a breeding farm associated with abortion and fatal interstitial pneumonia in neonatal foals. Wernery U., Wade J.F., Mumford J.A., Kaaden O.-R. Equine Infectious Diseases VIII. 1999;559-560 R&W Publications (Newmarket) Limited, Newmarket, UK.
31. Patton J.F., Balasuriya U.B.R., Hedges J.F., Schweidler T.M., Hullinger P.J., MacLachlan N.J. Phylogenetic characterization of a highly attenuated strain of equine arteritis virus from the semen of a persistently infected standardbred stallion. Arch. Virol. 144:1999;817-827.
32. Pedersen K.W., van der Meer Y., Roos N., Snijder E.J. Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex. J. Virol. 73:1999;2016-2026.
33. Snijder E.J. Arteriviruses. Knipe D.M., Howley P.M. Fields Virology. 2001;1205-1220 Lippincott Williams and Wilkins, Philadelphia, PA.
34. Snijder E.J., Meulenberg J.J.M. The molecular biology of arteriviruses. J. Gen. Virol. 79:1998;961-979.
35. Snijder E.J., van Tol H., Pedersen K.W., Raamsman M.J.B., de Vries A.A.F. Identification of a novel structural protein of arteriviruses. J. Virol. 73:1999;6335-6345.
36. Snijder E.J., Dobbe J.C., Spaan W.J.M. Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. J. Virol. 77:2003;97-104.
37. Timoney P.J., McCollum W.H. Equine viral arteritis. Vet. Clin. N. Am. Equ. Pract. 9:1993;295-309.
38. Timoney P.J., McCollum W.H., Roberts A.W., Murphy T.W. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res. Vet. Sci. 41:1986;279-280.
39. Timoney P.J., McCollum W.H., Murphy T.W., Roberts A.W., Willard J.G., Carswell G.D. The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of virus transmission. J. Reprod. Fertil. Suppl. 35:1987;95-102.
40. van der Meer Y., van Tol H., Locker J.K., Snijder E.J. ORF1a-Encoded replicase subunits are involved in the membrane association of the arterivirus replication complex. J. Virol. 72:1998;6689-6698.
41. van Dinten L.C., den Boon J.A., Wassenaar A.L.M., Spaan W.J.M., Snijder E.J. An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc. Natl. Acad. Sci. U.S.A. 94:1997;991-996.
42. Wagner H.M., Balasuriya U.B.R., MacLachlan N.J. The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and non-structural viral proteins. Comp. Immunol. Microbiol. Infect. Dis. 26:2003;251-260.
43. Westcott D., Lucas M., Paton D. Equine arteritis virus: antigenic analysis of strain variation. Schwyzer M., Ackermann M. Immunobiology of Viral Infections: Proc. 3rd Congress European Society for Veterinary Virology, Fondation Marcel Mev́rieux, 17 rue Bourgelat, Lyon, France. 1995;479-483.
44. Wieringa R., de Vries A.A.F., Raamsman M.J., Rottier P.J. Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus. J. Virol. 76:2003;10829-10840.